Russian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
lectin/злокачественная опухоль
Ссылка сохраняется в буфер обмена
Страница 1 от 87 полученные результаты
Method for diagnosing cancer using lectin
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS-REFERENCES TO RELATED APPLICATION
This patent application claims the benefit of priority from Korean Patent Application No. 10-2012-0031277, filed on Mar. 27, 2012, the contents of which are incorporated herein by reference.
REFERENCE TO A SEQUENCE LISTING
This application contains a Sequence
C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
REFERENCE TO SEQUENCE LISTING SUBMITTED VIA EFS-WEB
The entire content of the following electronic submission of the sequence listing via the USPTO EFS-WEB server, as authorized and set forth in MPEP .sctn.1730 II.B.2(a)(C), is incorporated herein by reference in its entirety for all purposes. The
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The invention described herein relates to a novel gene and its encoded protein, termed PC-LECTIN, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers that express PC-LECTIN, particularly prostate cancers.
BACKGROUND OF THE
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The invention described herein relates to a novel gene and its encoded protein, termed PC-LECTIN, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers that express PC-LECTIN, particularly prostate cancers.
BACKGROUND OF THE
C-type LECTIN transmembrane antigen expressed in human prostate cancer and uses thereof
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The invention described herein relates to a novel gene and its encoded protein, termed PC-LECTIN, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers that express PC-LECTIN, particularly prostate cancers.
BACKGROUND OF THE
C-type LECTIN transmembrane antigen expressed in human prostate cancer and uses thereof
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The invention described herein relates to a novel gene and its encoded protein, termed PC-LECTIN, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers that express PC-LECTIN, particularly prostate cancers.
BACKGROUND OF THE
Targeting of podoplanin with lectin for use in the prevention and treatment of cancer
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
Progress in methods to detect and treat cancer has led to increased five-year survival rates. However, cancer mortality rates have not decreased proportionately (Welch, et al. (2000) JAMA 283:2975-2978). Some transformed cells can survive medical treatment and lay dormant
Targeting of podoplanin with lectin for use in the prevention and treatment of cancer
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
Progress in methods to detect and treat cancer has led to increased five-year survival rates. However, cancer mortality rates have not decreased proportionately (Welch, et al. (2000) JAMA 283:2975-2978). Some transformed cells can survive medical treatment and lay dormant
Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD OF THE INVENTION
This invention relates to carbohydrate-binding proteins (lectins) of mammalian tumor cells which specifically recognize and bind to carbohydrate molecules and to methods of isolating these lectins from mammalian tumor cells.
BACKGROUND ART
The designation "lectin" is
Lectin like protein substance, method of obtaining same and anti-tumor agent comprising same
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a novel lectin like protein substance, method of obtaining same and anti-tumor agent comprising the same as an effective ingredient. The substance is produced through a cultivation of an insect cell and more
Medicament containing recombinant mistletoe lectins for the treatment of brain tumors
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a national stage application (under 35 U.S.C. .sctn. 371) of PCT/EP2017/053429, filed Feb. 15, 2017, which claims benefit of European Application No. 16155735.0, filed Feb. 15, 2016, both of which are incorporated herein by reference in
Method for extraction lectin from Chaenomeles lagenaria, medical composition for inhibiting tumor growth, biological reagent for detecting glycophorin A on blood and blood typing kit
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates to a Chaenomeles lagenaria extract and a method for extracting the same, and more particularly, to a Chaenomeles lagenaria extract that is effective in tumor growth inhibition and applicable to blood typing and method for
Immunoelectrophoresis method for diagnosing and differentiating cancer using lectins
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
BACKGROUND OF THE INVENTION
1. Field of Invention
This invention relates to a method for diagnosing cancer by qualitative and quantitative determination according to an immuno-serological assay of cancer-related antigens in a body fluid, particularly glycoprotein, glycolipid and glycoantigen
C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
FIELD OF THE INVENTION
The invention described herein relates to a novel gene and its encoded protein, termed PC-LECTIN, and to diagnostic and therapeutic methods and compositions useful in the management of various cancers that express PC-LECTIN, particularly prostate cancers.
BACKGROUND OF THE
Method for discriminating between prostate cancer and a benign prostate disease
Только зарегистрированные пользователи могут переводить статьи
Войти Зарегистрироваться
TECHNICAL FIELD
The present invention relates to a method of analyzing diagnostic information pertaining to a benign prostate disease and prostate cancer. The present invention also relates to a method of analyzing diagnostic information based on the blood concentration of mucin-1 having a specific
Самая полная база данных о лекарственных травах, подтвержденная наукой
- Работает на 55 языках
- Травяные лекарства, подтвержденные наукой
- Распознавание трав по изображению
- Интерактивная карта GPS - отметьте травы на месте (скоро)
- Прочтите научные публикации, связанные с вашим поиском
- Ищите лекарственные травы по их действию
- Организуйте свои интересы и будьте в курсе новостей исследований, клинических испытаний и патентов
Введите симптом или заболевание и прочтите о травах, которые могут помочь, введите лекарство и узнайте о болезнях и симптомах, против которых оно применяется.
* Вся информация основана на опубликованных научных исследованиях.
